Suvorexant: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

6 June 2024

  • curprev 03:3603:36, 6 June 2024Ai talk contribs 5,861 bytes +5,861 Created page with "== Introduction == '''Suvorexant''' is a medication used for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. It belongs to a class of drugs known as orexin receptor antagonists and works by blocking the action of orexin, a neurotransmitter involved in the regulation of the sleep-wake cycle. Suvorexant is marketed under the brand name Belsomra and was developed by Merck & Co. It was approved by the U.S. Food and Drug Adm..."